Glucose Homeostasis
The Pentose Phosphate Pathway: NADPH and Five-Carbon Sugars
Glycolysis is not the only fate of glucose-6-phosphate. At that branch point, a cell can route the sugar into the pentose phosphate pathway instead, and walk away with two things glycolysis never makes: NADPH, the reducing power for building molecules and quenching reactive oxygen, and ribose-5-phosphate, the backbone of every nucleotide. It makes no ATP, and that is the point. Every cell that divides, and every cell that must defend itself against oxidative damage, depends on it.
Glucose-6-phosphate stands at a fork. One road is glycolysis, which you already know: ten steps, two ATP earned, energy as the goal. The other road is the pentose phosphate pathway, and it earns no ATP at all. A cell that takes it walks away with two prizes glycolysis never offers — NADPH, the reducing power for building molecules and disarming reactive oxygen, and ribose-5-phosphate, the sugar backbone of every nucleotide.
That trade — energy for building blocks and antioxidant defense — is why the pathway matters. Every cell that divides needs it, because no cell makes DNA without ribose. Every cell under oxidative stress needs it, because NADPH is what keeps the cell’s antioxidant machinery loaded. The red blood cell carrying oxygen past your retina right now is running it as its only source of NADPH.
Two ledgers the cell keeps apart
Here is the design principle that makes the whole chapter click. The cell runs two separate accounts of nicotinamide cofactor, and it keeps them apart on purpose.
The NAD+/NADH pool sits at roughly 1000:1 in favor of the oxidized form. Plenty of NAD+ standing ready to accept electrons is exactly what catabolism wants — glycolysis and the citric acid cycle are constantly pulling electrons off fuel. The NADP+/NADPH pool sits the other way, near 1:10 in favor of the reduced form. Plenty of NADPH standing ready to donate electrons is what anabolism wants — fatty-acid synthesis, nucleotide synthesis, and glutathione regeneration all spend reducing power.
The two molecules differ by one phosphate group, and that single tag is enough for enzymes to tell them apart. Why bother? Because if the cell pooled them, the abundant NAD+ would constantly drain the NADPH the cell worked to build, and biosynthesis would fight catabolism in a futile cycle. Keeping them separate lets the cell run both directions at once. At the glucose-6-phosphate fork, phosphoglucose isomerase pulls toward glycolysis and ATP; glucose-6-phosphate dehydrogenase pulls toward the PPP and NADPH.
The oxidative phase: irreversible, and that is the point
The first three steps are a one-way street, and they are where both NADPH molecules and the pathway’s signature carbon loss happen.
Glucose-6-phosphate dehydrogenase (G6PD) opens the door. It oxidizes glucose-6-phosphate and reduces the first NADP+ to NADPH. This is the committed, rate-limiting step, and it is the regulated one. Lactonase then cracks open the strained lactone ring to give 6-phosphogluconate. 6-phosphogluconate dehydrogenase makes the second NADPH and, in the same breath, lops off a carbon as CO2, leaving the five-carbon ribulose-5-phosphate.
That lost carbon is what locks the phase shut. You can push a sugar through a reversible rearrangement, but you cannot reach out and stick a CO2 molecule back on. The net is worth memorizing:
G6P + 2 NADP+ + H2O → ribulose-5-P + 2 NADPH + 2 H+ + CO2
Two NADPH, one CO2, no ATP. The CO2 matters because the oxidative phase releases it without consuming O2, unlike full glucose oxidation. Hummingbirds, which sustain the highest mass-specific metabolic rate of any vertebrate and generate enormous reactive-oxygen loads, lean on this phase heavily for antioxidant defense.
The non-oxidative phase: carbon, shuffled
Now the cell faces a logistics problem. It often needs more NADPH than ribose, or more ribose than NADPH. The non-oxidative phase is the accounting trick that lets it rebalance, and unlike the oxidative phase, every step here is reversible.
Two routing enzymes set up the sugars. Phosphopentose isomerase turns ribulose-5-phosphate into ribose-5-phosphate, the aldose that exits toward nucleotide synthesis. Phosphopentose epimerase turns ribulose-5-phosphate into xylulose-5-phosphate, its epimer, differing at a single stereocenter. Then three transfer reactions reshuffle the carbons:
- Transketolase (Chris’s “molecular scissors”) snips a two-carbon unit off xylulose-5-P and welds it onto ribose-5-P: C5 + C5 → C3 (glyceraldehyde-3-P) + C7 (sedoheptulose-7-P). It runs on thiamine pyrophosphate, the same cofactor pyruvate dehydrogenase uses.
- Transaldolase moves a three-carbon unit: C7 + C3 → C6 (fructose-6-P) + C4 (erythrose-4-P). It needs no external cofactor — it uses an active-site lysine to form a Schiff base, exactly the mechanism aldolase uses in glycolysis.
- Transketolase again: C4 + C5 → C6 (fructose-6-P) + C3 (glyceraldehyde-3-P).
Stand back and the whole phase reduces to one tidy equation: three C5 sugars become two fructose-6-P and one glyceraldehyde-3-P. Check the carbons — 3 × 5 = 15, and 2 × 6 + 3 = 15. Both products are glycolytic intermediates, so the carbon can flow straight back into the energy pathway.
Walk the interactive below. Each metabolite carries a carbon-count badge so you can verify the arithmetic at every cut, and the mode selector lets you watch the pathway re-route to match demand.
The committed, rate-limiting step. Oxidizes C1 of glucose-6-phosphate and reduces NADP⁺ to the first NADPH. This is the door into the pathway, and the cell holds it shut when NADPH is plentiful.
Clinical. G6PD deficiency affects ~400 million people. With G6PD weak, red cells cannot regenerate NADPH, glutathione falls, hemoglobin oxidizes into Heinz bodies, and the spleen destroys the cells — a hemolytic crisis triggered by fava beans, certain drugs, or infection. The same allele is hostile to the malaria parasite, which is why it persists where malaria is endemic.
Hydrolyzes the strained lactone ring open to the linear acid. A quiet housekeeping step that also occurs slowly on its own, but the enzyme makes it fast and clean.
Oxidative decarboxylation: makes the second NADPH and releases C1 as CO₂. Losing that carbon is what makes the whole oxidative phase irreversible — you can run a sugar uphill, but you cannot put a CO₂ back.
Clinical. Because this step releases CO₂ without consuming O₂ (unlike full glucose oxidation), tissues running the PPP hard add CO₂ disproportionately — a useful illustration of heavy PPP flux, not a clinical diagnostic on its own.
Ketose → aldose. This is the exit toward biosynthesis: ribose-5-phosphate is the sugar backbone of every nucleotide, so this branch feeds DNA, RNA, ATP, NAD⁺, and coenzyme A.
Clinical. Ribose-5-phosphate is the precursor of PRPP, the activated sugar that starts both purine and pyrimidine synthesis — the reason every dividing cell needs this pathway.
Inverts the configuration at a single carbon (C3). Ribulose and xylulose are epimers, identical except at that one stereocenter, but transketolase needs xylulose, so the small change matters.
Molecular scissors: snips a two-carbon ketol unit off xylulose and welds it onto ribose. Requires thiamine pyrophosphate (TPP), the same cofactor pyruvate dehydrogenase uses. Carbon check: 5 + 5 = 3 + 7.
Clinical. TPP comes from vitamin B1 (thiamine). In thiamine deficiency (Wernicke-Korsakoff, classically in alcoholism) transketolase activity falls — the assay for it is a clinical test of thiamine status.
Transfers a three-carbon dihydroxyacetone unit using an active-site lysine that forms a Schiff base with the substrate, the same trick aldolase uses in glycolysis. No external cofactor. Carbon check: 7 + 3 = 6 + 4.
Transketolase again, second cut, moving another two-carbon unit so both end products are ordinary glycolytic intermediates. Carbon check: 4 + 5 = 6 + 3. Net of the non-oxidative phase: three C5 sugars become two F6P and one G3P.
Four modes: one pathway, four answers
Because the non-oxidative phase is reversible, the cell can run the PPP in whichever direction the moment requires. Pick a demand below and watch which branches fire:
- Net output
- —
- Where you see it
- —
The same enzymes, run forward or backward in different proportions, let one pathway serve four very different cellular needs.
The oxidative branch (G6PD onward) is one-way and makes NADPH + CO₂. The non-oxidative branch (transketolase / transaldolase) is fully reversible, so the cell runs it whichever way the demand points.
Chris’s four nicknames:
- Mode 1, the “ribose builder.” A cell needs ribose but already has plenty of NADPH. It skips the oxidative phase entirely and runs the non-oxidative steps backward, building ribose-5-P out of fructose-6-P and glyceraldehyde-3-P pulled from glycolysis. No NADPH made.
- Mode 2, the “balanced trader.” Ribose and NADPH are needed in equal measure. Run the oxidative phase, then isomerize ribulose-5-P to ribose-5-P. Two NADPH and one ribose per glucose.
- Mode 3, the “NADPH baron” (the name is about reducing power, not ATP). A cell wants maximum NADPH and little ribose — think liver or fat tissue making fatty acids. Run the oxidative phase, then use the non-oxidative phase forward to recycle the ribose carbons back to glucose-6-phosphate, which loops through again. Many NADPH, almost no leftover ribose.
- Mode 4, the “resourceful alchemist.” A cell wants NADPH and ATP. Run the oxidative phase for NADPH, then feed the fructose-6-P and glyceraldehyde-3-P straight into glycolysis. No net ribose.
The throttle behind all four is one number: NADP+ concentration. G6PD is product-inhibited by NADPH. When the cell spends NADPH on biosynthesis or on fighting oxidative damage, NADP+ rises, the inhibition lifts, and the oxidative phase accelerates. The pathway answers demand without any hormone or second messenger — feedback written directly into the active site.
Why a fava bean can be dangerous
Here is the clinical payoff, and it starts with a medical mystery: why do some people suffer a sudden, severe anemia after eating fava beans?
NADPH from the PPP is what keeps glutathione reduced. Glutathione is a small tripeptide (γ-Glu-Cys-Gly) with a reactive cysteine thiol, and it is the cell’s frontline antioxidant. Glutathione peroxidase spends reduced glutathione (GSH) to neutralize peroxides, turning it into the oxidized disulfide GSSG; glutathione reductase then spends NADPH to turn GSSG back into GSH. The whole cycle leans on the PPP. Cut off the NADPH and the antioxidant defense collapses.
G6PD deficiency — the most common enzyme deficiency on Earth, affecting roughly 400 million people — does exactly that. The cascade is clean: G6PD↓ → NADPH↓ → GSH↓ → reactive oxygen accumulates → hemoglobin oxidizes and clumps into Heinz bodies → the spleen culls the damaged cells → hemolytic crisis. Red blood cells are uniquely exposed. They have no nucleus, so they cannot transcribe more enzyme, and no mitochondria, so the PPP is their only source of NADPH. Fava beans, certain antimalarial and sulfa drugs, and infection all push oxidative stress past what a weakened cell can handle.
Then the evolutionary plot twist. The deficiency persists because it is protective: G6PD-deficient red cells are a hostile environment for Plasmodium falciparum, the malaria parasite. Map the allele’s prevalence and it mirrors the historical range of malaria. The same trait that risks hemolysis bought survival against a deadlier threat — a balanced polymorphism, the textbook companion to sickle-cell trait. The practical lesson: screen for G6PD before prescribing an oxidative-stress drug.
The PPP also closes a loop back to cancer, which the next chapters develop. Dividing tumor cells run glycolysis hard (the Warburg effect) and the PPP hard, because they need NADPH for lipid and nucleotide synthesis and for surviving their own oxidative stress. The tumor suppressor p53 normally restrains G6PD by blocking its assembly into the active dimer; lose p53 — the single most common cancer mutation — and the brake comes off, and PPP flux climbs. Carry that pairing forward: the same NADPH economy you just learned is the one the most dangerous cells exploit. From here we follow glucose-6-phosphate’s carbons the other direction, into the citric acid cycle.
How we measure it
Respiratory quotient (RQ = CO2/O2)
Measure the ratio of CO2 exhaled to O2 consumed and you can read which fuel a tissue is burning. Pure carbohydrate oxidation gives RQ ≈ 1.0; fat gives ≈ 0.7. The oxidative phase of the PPP is unusual in releasing CO2 without consuming O2, so heavy PPP flux nudges the ratio upward; at the whole-organism level, though, an RQ above 1.0 more often reflects net fat synthesis. Read it as an illustration of CO2-without-O2 chemistry, not a clean PPP assay.
Isotopic carbon tracing
Feed cells glucose labeled at a specific carbon (13C or 14C on C1 vs C6) and follow where the atom lands. Because the oxidative phase removes C1 of glucose as CO2 while glycolysis would keep it, the position of the released label tells you what fraction of glucose ran the PPP versus glycolysis. This is how the relative flux through the two branches was first measured in different tissues.
Enzyme assay for G6PD (the clinical screen)
Glucose-6-phosphate dehydrogenase activity is measured by following NADPH production spectrophotometrically (NADPH absorbs at 340 nm; NADP+ does not). A drop in the rate of A340 rise in a patient's red cells is the standard diagnostic for G6PD deficiency — the same initial-velocity logic from enzyme kinetics, used to decide whether an oxidative-stress drug is safe to prescribe.
Glutathione redox ratio (GSH/GSSG)
The ratio of reduced glutathione to its oxidized disulfide form is a readout of a cell's antioxidant reserve, and it is held high entirely by NADPH from the PPP. Measuring GSH/GSSG (by HPLC or enzymatic recycling assays) reports whether the pathway is keeping up with oxidative demand — it collapses when NADPH supply fails.